Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lindal Group is a global leader in the design, development, and manufacture of aerosol valves, actuators, and spray caps, with a specialized division dedicated to the pharmaceutical industry. The company provides advanced drug delivery solutions, including metered-dose inhalers (MDIs) and Bag-on-Valve (BOV) technology, which are essential for respiratory, nasal, and topical treatments. Lindal Pharma focuses on high-precision engineering and regulatory compliance, offering both standard and customized components for healthcare applications. Their global manufacturing network operates under stringent quality standards such as ISO 15378 to ensure the safety and efficacy of medicinal packaging. By partnering with major pharmaceutical firms, Lindal Group facilitates the delivery of complex formulations through innovative aerosol systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lindal Group.